AKEBIA THERAPEUTICS, INC. (AKBA)

Import this data to Google Sheets with:

=jivedata("AKBA","financials")

Full statements spill as a table. For one cell: =jivedata("AKBA","Revenue") or =jivedata("AKBA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

AKEBIA THERAPEUTICS, INC.

AKBA • CIK 0001517022

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-46,256	$-50,472	$23,499	$-15,126
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-51,925	$-69,410	$-3,721	$-27,846
Income Tax Expense (Benefit)	—	—	$1,624	$1,820
Net Income (Loss) Attributable to Parent	$-51,925	$-69,410	$-5,345	$-29,666
Revenue from Contract with Customer, Excluding Assessed Tax	$194,623	$160,180	$236,196	$219,060
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$38,107	$27,135	$39,462	$44,632
Cost, Amortization	$36,042	$36,042	$0	$0
Cost of Revenue	$74,149	$63,177	$39,462	$44,632
Research and Development Expense	$63,079	$37,652	$62,359	$70,458
Selling, General and Administrative Expense	$100,233	$106,545	$107,480	$113,790
Restructuring Charges	$181	$58	$0	$1,945
Operating Expenses	$166,730	$147,475	$173,235	$189,554
Interest Income (Expense), Nonoperating, Net	$-6,032	$-18,185	$-24,179	$-17,337
Other Nonoperating Income (Expense)	$887	$94	$58	$-131
Fair Value Adjustment of Warrants	—	$330	$3,099	$-4,748
Gain (Loss) on Extinguishment of Debt	$0	$-517	$0	$0
Gain (Loss) on Termination of Lease	$-524	$0	$0	$0
Weighted Average Number of Shares Outstanding, Basic	187,465,448	210,946,658	257,157,782	276,383,211

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$42,925	$51,870	$184,844	$155,548
Inventory, Net	$15,691	$16,243	$15,610	$13,018
Property, Plant and Equipment, Net	$3,629	$2,200	$1,222	$1,514
Accounts Receivable, after Allowance for Credit Loss, Current	$39,290	$34,368	$47,031	$53,506
Operating Lease, Right-of-Use Asset	$12,416	$8,218	$3,663	$5,800
Prepaid Expense and Other Assets, Current	$20,243	$11,350	$5,470	$7,481
Goodwill	$59,044	$59,044	$59,044	$59,044
Assets, Current	$118,149	$113,831	$252,955	$229,553
Other Assets, Noncurrent	$12,423	$37,377	$59,681	$53,747
Assets	$241,703	$220,670	$376,565	$349,658
Operating Lease, Liability, Noncurrent	$8,947	$3,547	$0	$4,400
Long-term Debt, Excluding Current Maturities	$17,183	$38,693	$48,250	$24,754
Contract with Customer, Refund Liability, Noncurrent	$40,093	$38,013	$22,606	$21,219
Derivative Liability, Noncurrent	—	$5,176	$2,980	$1,958
Other Liabilities, Noncurrent	$8,885	$4,749	$1,823	$562
Liabilities	$272,287	$269,855	$343,955	$324,640
Accounts Payable, Current	$14,635	$15,180	$21,185	$9,422
Accrued Liabilities, Current	$67,735	$63,460	$121,716	$109,797
Contract with Customer, Liability, Current	$0	—	$2,681	$6,169
Contract with Customer, Refund Liability, Current	—	$2,274	$17,356	$10,668
Liabilities, Current	$99,870	$80,914	$162,938	$160,865
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2	$2	$2	$2
Additional Paid in Capital, Common Stock	$1,578,358	$1,629,167	$1,716,307	$1,726,677
Accumulated Other Comprehensive Income (Loss), Net of Tax	$6	$6	$6	$6
Retained Earnings (Accumulated Deficit)	$-1,608,950	$-1,678,360	$-1,683,705	$-1,701,667
Stockholders' Equity Attributable to Parent	$-30,584	$-49,185	$32,610	$25,018
Preferred Stock, Shares Authorized	25,000,000	25,000,000	25,000,000	25,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	350,000,000	350,000,000	350,000,000	500,000,000
Common Stock, Shares, Issued	194,582,539	224,848,992	265,424,818	271,742,717
Prepaid Expense, Current	—	$28,400	$0	$0
Restricted Cash, Current	—	—	$1,699	$1,708
Other Assets, Current	$5,754	$7,321	$3,771	$5,773
Inventory, Noncurrent	$9,403	$34,953	$59,129	$53,272
Restricted Cash, Noncurrent	$1,654	$1,680	$0	$0
Other Assets, Miscellaneous, Noncurrent	$1,366	$744	$552	$475
Employee-related Liabilities, Current	$8,216	$9,194	$11,018	$7,348
Operating Lease, Liability, Current	$4,491	$5,400	$3,548	$1,006
Accrued Royalties, Current	$3,989	$3,543	$3,924	$2,458
Accrued Professional Fees, Current	$1,909	$1,452	$1,597	$1,572
Restructuring Reserve, Current	$737	$489	$0	$1,688
Other Accrued Liabilities, Current	$4,602	$3,840	$4,488	$2,688

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-51,925	$-69,410	$-5,345	$-29,666
Net Cash Provided by (Used in) Operating Activities	$-23,384	$-40,659	$67,992	$41,552
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-48,590	$8,971	$132,993	$18,258
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$44,579	$53,550	$186,543	$235,832
Depreciation	$1,585	$1,462	$1,269	$1,552
Payments to Acquire Property, Plant, and Equipment	$0	$33	$291	$1,288
Amortization of Intangible Assets	$36,042	$36,042	$0	$0
Proceeds from Sale of Property, Plant, and Equipment	—	—	$172	$0
Payments to Acquire in Process Research and Development	—	—	$7,807	$10,807
Fair Value Adjustment of Warrants	—	$330	$3,099	$-4,748
Net Cash Provided by (Used in) Investing Activities	$0	$-33	$-7,926	$-12,095
Straight Line Rent	—	—	$-4,555	$-4,746
Write off of Deferred Debt Issuance Cost	$0	$294	$0	$0
Gain (Loss) on Contract Termination	$825	$0	$0	$0
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	—	$12,807	$12,807
Inventory Write-down	$1,600	$4,208	$2,505	$7,333
Share-based Payment Arrangement, Noncash Expense	$9,317	$7,775	$11,283	$13,314
Increase (Decrease) in Derivative Liabilities	$-760	$0	$0	$0
Proceeds from Issuance of Debt	—	$45,000	$10,000	$0
Payments of Debt Issuance Costs	—	$1,272	$63	$0
Proceeds from Stock Plans	$85	$154	$230	$283
Proceeds from Stock Options Exercised	$1	$385	$1,684	$1,129
Repayments of Debt	—	$37,099	$462	$0
Net Cash Provided by (Used in) Financing Activities	$-25,206	$49,663	$72,927	$-11,199
Interest Paid, Excluding Capitalized Interest, Operating Activities	$6,059	$5,035	$6,080	$6,080
Increase (Decrease) in Accounts Receivable	$-994	$-4,046	$14,142	$-18,585
Increase (Decrease) in Inventories	$2,542	$28,401	$23,125	$13,714
Increase (Decrease) in Prepaid Expense and Other Assets	$-11,839	$-8,893	$-7,579	$-2,059
Increase (Decrease) in Other Noncurrent Assets	$1,361	$-622	$2,622	$3,435
Increase (Decrease) in Accounts Payable	$-5,244	$-1,364	$3,082	$-3,599
Increase (Decrease) in Accrued Liabilities	$-10,021	$-12,777	$48,530	$26,346
IncreaseDecreaseInOperatingLeaseLiability	$-4,963	$-4,491	$-5,399	$-5,363
Increase (Decrease) in Contract with Customer, Liability	$-3,738	$0	$2,681	$637
Increase (Decrease) in Other Noncurrent Liabilities	$-5,691	$-6,204	$-112	$-1,191

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("AKBA","financials")

Full statements spill as a table. For one cell: =jivedata("AKBA","Revenue") or =jivedata("AKBA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.